[1] Malinoski D, Ewing T, Bhakta A, et al. Which central venous catheters have the highest rate of catheter-associated deep venous thrombosis:a prospective analysis of 2,128 catheter days in the surgical intensive care unit[J]. J Trauma Acute Care Surg, 2013, 74(2):454-460. [2] Chopra V, Anand S, Krein SL, et al. Bloodstream infection, venous thrombosis, and peripherally inserted central catheters:reappraising the evidence[J]. Am J Med, 2012, 125(8):733-741. [3] Mustafa S, Stein PD, Patel KC, et al. Upper extremity deep venous thrombosis[J]. Chest, 2003, 123(6):1953-1956. [4] Kuter DJ. Thrombotic complications of central venous catheters in cancer patients[J]. Oncologist, 2004, 9(2):207-216. [5] Young AM, Billingham LJ, Begum G, et al. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP):an open-label randomised trial. Lancet, 2009, 373(9663):567-574. [6] Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters[J]. Chest, 2010, 138(4):803-810. [7] Joffe HV, Kucher N, Tapson VF, et al. Upper-extremity deep vein thrombosis a prospective registry of 592 patients[J]. Circulation, 2004, 110(12):1605-1611. [8] Hingorani A, Ascher E, Lorenson E, et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population[J]. J Vasc Surg, 1997, 26(5):853-860. [9] Hingorani A, Ascher E, Marks N, et al. Morbidity and mortality associated with brachial vein thrombosis[J]. Ann Vasc Surg, 2006, 20(3):297-300. [10] Joffe HV, Goldhaber SZ. Upper extremity deep vein thrombosis[J]. Circulation, 2002, 106(14):1874-1880. |